1
Clinical Trials associated with DWC-202405 / Active, not recruitingPhase 3 A Multi-center, Randomized, Double-blind, Parallel Design, Phase III Study to Evaluate and Compare the Efficacy and Safety of DWC202405/DWC202313 and DWC202314 Combination Therapy to DWC202405/DWC202313 in Patients With Essential Hypertension Inadequately Controlled With DWC202405
A Multi-center, Randomized, Double-blind, Parallel design, Phase III study to Evaluate and Compare the Efficacy and Safety of DWC202405/DWC202313 and DWC202314 Combination Therapy to DWC202405/DWC202313 in Patients with Essential Hypertension Inadequately Controlled with DWC202405
100 Clinical Results associated with DWC-202405
100 Translational Medicine associated with DWC-202405
100 Patents (Medical) associated with DWC-202405
100 Deals associated with DWC-202405